Daelim Paper Co.Ltd (017650) — Free Cash Flow Generation Index

Latest as of September 2025: 0.85x

Daelim Paper Co.Ltd (017650) has a Free Cash Flow Generation Index of 0.85x as of September 2025. Free cash flow of ₩4.43 Billion represents 1% of operating cash flow (₩5.21 Billion). Read debt load of Daelim Paper Co.Ltd for a breakdown of total debt and financial obligations.

FCF Generation Index

0.85x
Free Cash Flow / Operating CF

Free Cash Flow

₩4.43 Billion
KRW

Operating Cash Flow

₩5.21 Billion
KRW

Capital Expenditures

₩777.47 Million
KRW

Daelim Paper Co.Ltd Free Cash Flow Generation Index (2011–2024)

Historical FCF Generation Index trend for Daelim Paper Co.Ltd across 12 annual periods. Explore capital reinvestment ratio of Daelim Paper Co.Ltd to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Daelim Paper Co.Ltd (2011–2024)

Year-by-year Free Cash Flow Generation Index for Daelim Paper Co.Ltd. For the full company profile including market capitalisation, see 017650 stock market capitalisation.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 -0.15x ₩-2.51 Billion ₩16.97 Billion ₩19.46 Billion ▼ -121.2%
2023 0.70x ₩20.60 Billion ₩29.50 Billion ₩8.91 Billion ▼ -23.7%
2022 0.92x ₩28.66 Billion ₩31.30 Billion ₩2.75 Billion ▲ +34.7%
2021 0.68x ₩16.89 Billion ₩24.84 Billion ₩7.95 Billion ▼ -28.8%
2020 0.96x ₩27.14 Billion ₩28.42 Billion ₩1.63 Billion ▼ -25.9%
2019 1.29x ₩22.41 Billion ₩17.39 Billion ₩5.02 Billion ▼ -47.2%
2018 2.44x ₩46.05 Billion ₩18.87 Billion ₩27.18 Billion ▼ -67.4%
2017 7.49x ₩38.97 Billion ₩5.21 Billion ₩33.76 Billion ▲ +184.0%
2016 2.64x ₩9.71 Billion ₩3.68 Billion ₩6.03 Billion ▼ -57.5%
2015 6.20x ₩10.69 Billion ₩1.72 Billion ₩8.96 Billion ▲ +399.0%
2012 1.24x ₩30.93 Billion ₩24.90 Billion ₩6.03 Billion ▼ -3.0%
2011 1.28x ₩1.31 Billion ₩1.02 Billion ₩287.00 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).